Last update 21 Nov 2024
pCAR-19B(Chongqing Precision Biotechnology)
Last update 21 Nov 2024
Overview
Basic Info
Drug Type CAR-T |
Synonyms Anti-CD19-Car T cell therapy, PCAR 19B, pCAR-19B细胞自体回输制剂(Chongqing Precision Biotechnology) |
Target |
Mechanism CD19 modulators(B-lymphocyte antigen CD19 modulators) |
Therapeutic Areas |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseNDA/BLA |
First Approval Date- |
RegulationPriority Review (CN), Breakthrough Therapy (CN) |
Login to view timeline
Related
9
Clinical Trials associated with pCAR-19B(Chongqing Precision Biotechnology)靶向CD19嵌合抗原受体T淋巴细胞（pCAR-19B）自体回输制剂治疗CD19阳性复发/难治性B细胞急性淋巴细胞白血病（22～70周岁）的Ⅱ期临床研究
[Translation] Phase II clinical study of autologous infusion of CD19-targeted chimeric antigen receptor T lymphocytes (pCAR-19B) in the treatment of CD19-positive relapsed/refractory B-cell acute lymphoblastic leukemia (22-70 years old)
A Clinical Study on the Safety and Efficacy of Chimeric Antigen Receptor T Cell Injection Targeting CD19 Gene in the Treatment of Refractory Systemic Lupus Erythematosus
靶向CD19嵌合抗原受体T淋巴细胞（pCAR-19B）自体回输制剂治疗CD19阳性复发/难治性B细胞急性淋巴细胞白血病的Ⅱ期临床研究
[Translation] Phase II clinical study of autologous infusion of chimeric antigen receptor T lymphocytes targeting CD19 (pCAR-19B) in the treatment of CD19-positive relapsed/refractory B-cell acute lymphoblastic leukemia
100 Clinical Results associated with pCAR-19B(Chongqing Precision Biotechnology)
Login to view more data
100 Translational Medicine associated with pCAR-19B(Chongqing Precision Biotechnology)
Login to view more data
100 Patents (Medical) associated with pCAR-19B(Chongqing Precision Biotechnology)
Login to view more data
1
Literatures (Medical) associated with pCAR-19B(Chongqing Precision Biotechnology)Scientific ReportsQ3 · CROSS-FIELD
MicroRNA pharmacogenomics based integrated model of miR-17-92 cluster in sorafenib resistant HCC cells reveals a strategy to forestall drug resistance
Q3 · CROSS-FIELD
ArticleOA
Author: Ahmad, Jamil ; Janjua, Hussnain Ahmed ; Ali, Amjad ; Obaid, Ayesha ; Naveed, Abdul Khaliq ; Ikram, Aqsa ; Naz, Anam ; Awan, Faryal Mehwish
100 Deals associated with pCAR-19B(Chongqing Precision Biotechnology)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| CD19-positive B-cell acute lymphoblastic leukemia | NDA/BLA | CN | 20 Jul 2024 | |
| CD19 Positive B-Cell Leukemia | Phase 2 | CN | 26 Jan 2022 | |
| Refractory Adult Acute Lymphoblastic Leukemia | Phase 2 | CN | 26 Jan 2022 | |
| Systemic Lupus Erythematosus | Phase 1 | CN | 04 Jan 2024 | |
| CD19 positive Non-Hodgkin Lymphoma | Phase 1 | CN | 06 Sep 2021 | |
| Non-Hodgkin's lymphoma refractory | Phase 1 | CN | 06 Sep 2021 | |
| Recurrent Non-Hodgkin Lymphoma | Phase 1 | CN | 06 Sep 2021 | |
| Recurrent B Acute Lymphoblastic Leukemia | Discovery | CN | 30 Oct 2020 | |
| Refractory B Acute Lymphoblastic Leukemia | Discovery | CN | 30 Oct 2020 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
NCT05334823 (ASH2024) Manual  | Phase 2 | 64 | (kfumufgdqf) = bmtneqzhls bzgbhqbdki (bndcatdxdm ) View more | Positive | 09 Dec 2024 | ||
NCT04888442 (ASH2022) Manual | Phase 1 | Pre B-cell acute lymphoblastic leukemia CD19 Positive | 9 | (pzbewrvxwr) = zqxylvivch djqmritkxr (rplfpyxevn ) View more | Positive | 15 Nov 2022 |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free